Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.49 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.49 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | ALB | P02768 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | VKORC1 | Q9BQB6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26724801 | 1.00 | TAAR1 (0.53) | TAAR1PLA2G1BATG4BKCNA3ALDH1A1 | |
| SCHEMBL25152144 | 0.86 | TAAR1 (0.55) | TAAR1PLA2G1BATG4BKCNA3MAPT | |
| SCHEMBL17050186 | 0.86 | TAAR1 (0.55) | TAAR1PLA2G1BATG4BKCNA3GPR139 | |
| SCHEMBL25152385 | 0.86 | TAAR1 (0.55) | TAAR1PLA2G1BATG4BKCNA3MAPT | |
| SCHEMBL1234229 | 0.86 | TAAR1 (0.55) | TAAR1PLA2G1BATG4BKCNA3MAPT | |
| SCHEMBL185647 | 0.82 | TAAR1 (0.57) | TAAR1PLA2G1BATG4BKCNA3ALDH1A1 | |
| SCHEMBL9857141 | 0.82 | PDPK1 (0.58) | ALDH1A1KDM4EMAPTCES2CES1 | |
| SCHEMBL26269490 | 0.82 | TAAR1 (0.52) | TAAR1KCNA3ALDH1A1MAPTKMT2A | |
| SCHEMBL11541498 | 0.81 | CYP2D6 (0.57) | ALDH1A1KDM4EMAPTKMT2ACES2 | |
| SCHEMBL9909376 | 0.79 | KCNA5 (0.64) | TAAR1PLA2G1BATG4BKCNA3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111285865-B | 9-demethylberberine derivative and preparation method and application thereof | 常州方圆制药有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-111285865-A | 9-demethylberberine derivative and preparation method and application thereof | 江阴高新科技发展有限公司 | 2020-06-16 | — | — | CN | disclosed |
| US-9156840-B2 | D2 antagonists, methods of synthesis and methods of use | Altos Therapeutics, LLC (US) | 2015-10-13 | — | — | US | disclosed |
| US-20140350005-A1 | D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-11-27 | — | — | US | disclosed |
| US-8691836-B2 | D2 antagonists, methods of synthesis and methods of use | Altos Therapeutics, LLC (US) | 2014-04-08 | — | — | US | disclosed |
| US-20120010228-A1 | D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE | Altos Therapeutics, LLC | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350005-A1 | D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE | DRD2, DRD3, AVPR2 | TAAR1 133/4885PLA2G1B 1534/4885ATG4B 4026/4885 |
| US-20120010228-A1 | D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE | DRD2, DRD3, AVPR2 | TAAR1 133/4885PLA2G1B 1534/4885ATG4B 4026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.